Johnson & Johnson (JNJ.US) pulmonary arterial hypertension drug approved for new indication
智通财经2026/11/05 09:10Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to reports from Zhihui Caijing APP, on November 5, the official website of the National Medical Products Administration (NMPA) showed that Johnson & Johnson (JNJ.US)'s macitentan dispersible tablets have been approved for market launch, with the presumed indication being pediatric pulmonary arterial hypertension.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Meta's Euro bond issuance sets a subscription record in Europe
智通财经•2026/11/05 10:07
European gas prices have retreated, but the tight fundamentals remain unchanged.
智通财经•2026/11/05 10:07
Crypto prices
More
Bitcoin
BTC
$80,416
+2.54%
Ethereum
ETH
$2,418.63
+4.08%
Tether USDt
USDT
$0.9991
+0.06%
BNB
BNB
$715.61
+1.99%
XRP
XRP
$1.32
+2.70%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$96.8
+3.70%
TRON
TRX
$0.3184
-0.85%
Zcash
ZEC
$1,326.59
+1.00%
Hyperliquid
HYPE
$82.68
-4.57%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now